Loading...
XHKG
2530
, Last price  
HKD
Name

Numans Health Food Holdings Co Ltd

Chart & performance

D1W1MN
XHKG:2530 chart
P/E
—
P/S
—
EPS
0.01
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
6.85%
Div Yld LY
—
Div Yld TTM
—
Revenues
184m
-33.54%
100,874,183104,638,090132,400,194337,608,000367,297,000426,545,000277,495,000184,435,773
Net income
5m
-92.84%
15,556,37617,209,45636,951,211119,670,00087,522,000159,344,00074,900,0005,360,576
CFO
47m
-43.99%
4,469,64515,510,98239,582,56693,994,00044,309,000150,568,00083,462,00046,749,913
Dividend
Jun 17, 20260.025 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Numans Health Food Holdings Company Limited focuses on the marketing, sale, and distribution of its Nemans-branded nutritional supplements across the People's Republic of China. Their extensive product range features algal oil docosahexaenoic acid (DHA), which supports brain and eye development in infants and children, and helps alleviate forgetfulness, anxiety, and postpartum depression in mothers. The company also offers probiotics, including solid drinks and lactic acid bacteria powders, to improve digestion and boost immunity for all ages. Other offerings include various vitamin and multi-nutrient products specifically formulated for pregnant women, infants, and children, as well as algal calcium and milk powders for diverse age groups. These products are distributed to consumers through both online platforms and traditional retail outlets. Established in Shanghai in 2002, Numans is a wholly-owned subsidiary of Far-East Fortune Management (China) Co., Ltd.
IPO date
Jan 10, 2025
Employees
Domiciled in
CN
Incorporated in
KY

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT